Literature DB >> 28504188

Discrepancy between clinical and pathological neck staging in oral cavity carcinomas.

Vânia Henriques1, Eduardo Breda2, Eurico Monteiro2.   

Abstract

INTRODUCTION: The presence of cervical lymph node metastases in patients with oral cavity squamous cell carcinoma reduces survival by up to 50%.
OBJECTIVE: The aims of this study are to assess the accuracy of clinical N staging versus pathological N staging and its impact on survival in order to identify predictive factors associated with the presence of occult neck metastases.
METHODS: Outcomes of 105 patients with oral cavity squamous cell carcinoma who underwent surgical treatment of the primary tumor and neck were retrospectively evaluated.
RESULTS: For pN0 and pN+ patients 5-year overall survival was respectively 53% and 27%; disease specific survival was 66% for pN0 and 33% for pN+. Patients with clinical negative lymph nodes were pathologically upstaged in 62% of cases. Disease specific survival according to staging discrepancy had statistically significant impact on survival (p=0.009).
CONCLUSION: Clinical staging usually underestimates the presence of nodal disease. Neck dissection should be performed in cN0 oral cavity squamous cell carcinoma.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. All rights reserved.

Entities:  

Keywords:  Carcinoma epidermoide; Cavidad oral; Estadiaje tumoral; Lymphatic metastases; Metastasis ganglionares; Neck dissection; Oral cavity; Squamous cell carcinoma; Supervivencia; Survival; Tumor staging; Vaciamiento carvical

Mesh:

Year:  2017        PMID: 28504188     DOI: 10.1016/j.otorri.2017.02.008

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp (Engl Ed)        ISSN: 2173-5735


  1 in total

1.  Comparative Analysis of Clinical and Pathological Lymph Node Staging Data in Head and Neck Squamous Cell Carcinoma Patients Treated at the General Hospital Vienna.

Authors:  Christina Eder-Czembirek; Birgit Erlacher; Dietmar Thurnher; Boban M Erovic; Edgar Selzer; Michael Formanek
Journal:  Radiol Oncol       Date:  2018-05-11       Impact factor: 4.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.